Sign in
8-K

Current Report

Prelude Therapeutics Inc Filed Acc 0001193125-20-285568

Material agreement

  • Item 1.01 Entry into a material definitive agreement

From the SEC's structured data for this filing

Loading d88737d8k.htm…